Thank you to our speakers, sponsors, and delegates who joined us in July! If you are interested in the 2025 event, please get in touch at info@hansonwade.com

REGISTER
EVENT GUIDE
PARTNER

Welcome to the In-House Impact: Life Sciences Summit 2024, dedicated to empowering in-house legal teams to transition from risk minimizers to business-critical commercial partners, enhancing strategic value and fostering organizational growth.

From improving operational efficiency through AI integration to fostering cross-functional collaboration, strategizing for successful IPOs, and understanding the mindset of executive leadership professionals, this event offered a unique platform for legal teams to exchange best practices in driving commercial influence within their life sciences companies.

60+ of your fellow GC’s, Chief Legal Officers, Risk Management, and Compliance experts from across leading pharma, biotech, medical device, and pharmaceutical services joined to successfully navigate developing compliance regulations, exchanged strategies in task prioritization, and secured a seat at the table as a commercial leader.

Our peers from 2024:

L

everaged insights gained from Disc Medicine, Beckman Coulter, American Regent, and Alexion to delve into the mindset of your Executive Leaders, understanding what keeps them up at night by analyzing strategic thinking processes and decision-making approaches to be a commercial asset

E

xamined the practical impact of AI integration within your organization by exploring the laws and regulations of AI to safeguard against risk, with AbbVie

G

rappled with the debate over whether the IRA is a bottleneck or blown out of proportion by analyzing theoretical versus actual risk with Immatics and Aveo Oncology

A

nalyzed best practices to ingrain compliance across the whole organization by brainstorming collaborative techniques, technology integrations, and training frameworks with Synolgic, Bridge Biosciences, Vivex, and Assertio Therapeutics

L

everaged first-hand insights from BMS and Alexion to ensure a smooth M&A transition by understanding the anticipated pain points experienced by each party, thereby mitigating risk and endorsing business continuity.

Your 2024 Expert Speaker Faculty Included:

Annie McGuire

General Counsel and Chief People Officer

Veracyte

Edward Sturchio

General Counsel & Corporate Secretary

Immatics GmbH

Gretchen Fritz

Chief Legal Officer & Vice President

American Regent - Inc

Holly Logue

Associate General Counsel

Gilead Sciences

Kyle Crossley

Head of Corporate Legal & Corporate Secretary

Corium International Inc.

Thomas Gnielinski

VP Associate General Counsel

Bridge Bioscience Corp

VIEW ALL 2024 SPEAKERS

Hear from Our Past Participants:

“Learning from other in-house counsel is so valuable, as we all deal with clients and outside counsel in a specific way. Meeting new people and building my network locally and beyond is priceless”

Takeda Pharmaceuticals

“In-House Impact looks set to occupy a truly unique and invaluable space in the industry, geared specifically towards General Counsels and their in-house teams within Life Sciences, furthering Legal’s role as a critical business growth enabler”

Roche Diagnostics

“This is one of the best conferences I have been to that focused on how to be a better business partner and thereby how to bring real value to our organization. And that is very valuable”

Anavir Pharmaceuticals

“This is my favorite conference annually. The focus on attorneys as business partners and hearing individual and collective experiences of business-focused, revenue-driving attorneys is invaluable”

J. Knipper & Company
REGISTER
EVENT GUIDE
PARTNER